How has Revolution Medicines, Inc.'s operating lease liabilities changed year-over-year?

Revolution Medicines, Inc.'s operating lease liabilities decreased by 38.1% year-over-year, from -$1.5M to -$2.07M.

Revolution Medicines, Inc. RVMD Operating lease liabilities

Operating lease liabilities at other companies

Amkor TechnologyAMKR

-$3.27M-730%

Guardant HealthGH

-$8.6M+10.0%

TJX CompaniesTJX

-$5M+37.5%

Lamar AdvertisingLAMR

-$36.27M-14.2%

Cloudflare, Inc.NET

-$23M-81.4%

RB GlobalRBA

-$38.4M-14.6%

Other financials

Income statement

See full

Revenue-—

Operating income-$445.2M-84.9%

Net income-$453.8M-113%

EPS (diluted)-$2.29-103%

Balance sheet

See full

Cash & equivalents$440.9M+32.2%

Total debt$156.6M+16.6%

Total equity$1.5B-27.8%

Total assets$2.3B-4.7%

Cash flow

See full

Operating cash flow-$354.2M-82.2%

CapEx$1.5M-52.9%

Free cash flow-$355.7M-79.9%

Valuation

See full

Market cap$34.65B+193%

Enterprise value$34.37B+198%

Profitability

See full

Operating margin-88,031.9%-89,488pp

Net margin-76,423.3%-77,733pp

Returns & leverage

See full

Return on equity-76.7%-923pp

Debt / equity0.1×0.0×

Current ratio6.8×-6.7×

Where this comes from

Reported directly by Revolution Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Revolution Medicines, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Revolution Medicines, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Revolution Medicines, Inc.'s operating lease liabilities?: Revolution Medicines, Inc. (RVMD) reported operating lease liabilities of -$2.07M in Q1 2026.
How has Revolution Medicines, Inc.'s operating lease liabilities changed year-over-year?: Revolution Medicines, Inc.'s operating lease liabilities decreased by 38.1% year-over-year, from -$1.5M to -$2.07M.